Vaccination in HIV-infected Patients
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Nearly 20 years into the HIV pandemic, vaccination of HIV-infected persons remains controversial. Although vaccine-preventable diseases are common in HIV, concerns about vaccine safety and lack of efficacy in this setting often lead to missed opportunities for vaccination. In this article, we review the literature regarding vaccine risks and benefits and offer recommendations regarding their use and timing in HIV-infected persons.
References
1.
Neuzil K, Reed G, Mitchel Jr E, Griffin M
. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA. 1999; 281(10):901-7.
DOI: 10.1001/jama.281.10.901.
View
2.
Farber C, Barath A, Dieye T
. The effects of immunization in human immunodeficiency virus type 1 infection. N Engl J Med. 1996; 335(11):817; author reply 818-9.
DOI: 10.1056/NEJM199609123351111.
View
3.
Krasinski K, Borkowsky W
. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA. 1989; 261(17):2512-6.
View
4.
Iorio A, Alatri A, Francisci D, Preziosi R, Neri M, Donatelli I
. Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. Vaccine. 1997; 15(1):97-102.
DOI: 10.1016/s0264-410x(96)00057-6.
View
5.
Frankel R, Virata M, Hardalo C, Altice F, Friedland G
. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis. 1996; 23(3):577-84.
DOI: 10.1093/clinids/23.3.577.
View